logo     Print Page  Close Window

Investor Overview

KemPharm uses its LATTM platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.


Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$2.80 + 0.051.82%6,599
Previous CloseToday's OpenIntraday HighIntraday Low
Exchange: NASDAQ (US Dollar)
08/17/17 11:02 a.m. ET
Refresh quote
Recent NewsMore >>
KemPharm, Inc. Reports Second Quarter 2017 Results
KemPharm Announces Preliminary Results from KP415 Pharmacokinetic Single and Multiple Dose Trial
KemPharm Announces Publication of Study of Intranasal Abuse of Hydrocodone Combination Products in Pharmacoepidemiology & Drug Safety
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources